An adenomyomatous polyp presenting as a large hypervascular tumor and its response to a gonadotropin-releasing hormone agonist

An adenomyomatous polyp presenting as a large hypervascular tumor and its response to a gonadotropin-releasing hormone agonist

Bibliographic Details
Main Authors:	Yu-Hung Lin, Yuh-Yu Chou, Lee-Wen Huang, Kok-Min Seow, Jiann-Loung Hwang
Format:	Article
Language:	English
Published:	Elsevier 2013-03-01
Series:	Taiwanese Journal of Obstetrics & Gynecology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1028455913000260

Similar Items

Low-resistance Flow in a Large Adenomyomatous Polyp Mimicking a Leiomyosarcoma
by: Sheng-Po Kao, et al.
Published: (2010-03-01)

Gonadotropin releasing hormone agonists: Expanding vistas
by: Navneet Magon
Published: (2011-01-01)

Adenomyomatous polyp causing acute urinary retention in a postmenopausal woman
by: Selver Özekinci, et al.
Published: (2011-09-01)

Effect of gonadotropin-releasing hormone agonist on ES-2 ovarian cancer cells
by: Kuan-Hao Tsui, et al.
Published: (2014-03-01)

Gonadotropin-releasing hormone agonist-induced pituitary apoplexy
by: Fergus Keane, et al.
Published: (2016-06-01)

Diffuse multiple giant adenomyomatous endometrial polyps: A rare case report
by: Atla Bhagyalakshmi, et al.
Published: (2018-01-01)

A Case of Thromboembolism After Injection of Gonadotropin-releasing Hormone Agonist
by: Feng Zhou, et al.
Published: (2016-01-01)

Ruptured Intramural Pregnancy with Low and Declining β-human Chorionic Gonadotropin Levels
by: Yu-Hung Lin, et al.
Published: (2005-03-01)

Gonadotropin-releasing hormone agonist ovulation trigger—beyond OHSS prevention
by: Juan Carlos Castillo, et al.
Published: (2020-04-01)

USE OF GONADOTROPIN-RELEASING HORMONE AGONISTS IN TREATMENT OF RECURRENT PRE-MENSTRUAL ENDOMETRIAL HYPERPLASIA
by: Yu. E. Dobrokhotova, et al.
Published: (2016-09-01)

Use of Buserelin depot, a gonadotropin-releasing hormone agonist, in the treatment of prostate cancer
by: L. M. Rapoport, et al.
Published: (2014-12-01)

Use of Buserelin depot, a gonadotropin-releasing hormone agonist, in the treatment of prostate cancer
by: L. M. Rapoport, et al.
Published: (2014-12-01)

A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
by: Jumpei Asakawa, et al.
Published: (2018-07-01)

The experimental production of adenomyomatous tumours
by: Hunter, J. W. A.
Published: (1932)

Thyroid Dysfunction Associated with Administration of the Long-Acting Gonadotropin-Releasing Hormone Agonist
by: Eun Jin Han, et al.
Published: (2013-09-01)

Aggressive angiomyxoma of the vulva: dramatic response to gonadotropin-releasing hormone agonist therapy
by: Azar Danesh, et al.
Published: (2007-08-01)

Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer
by: Choi S, et al.
Published: (2011-12-01)

Comparative proteomics reveal negative effects of gonadotropin-releasing hormone agonist and antagonist on human endometrium
by: Chen Q, et al.
Published: (2019-05-01)

Influence of Gonadotropin Hormone Releasing Hormone Agonists on Interhemispheric Functional Connectivity in Girls With Idiopathic Central Precocious Puberty
by: Tao Chen, et al.
Published: (2020-01-01)

Long-term outcomes after gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty.
by: Young Suk Shim, et al.
Published: (2020-01-01)

Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve
by: Ming-Huei Lin, et al.
Published: (2019-01-01)

Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty.
by: Hae Sang Lee, et al.
Published: (2018-01-01)

Increased risk of pneumonia in patients receiving gonadotropin-releasing hormone agonists for prostate cancer.
by: Shiu-Dong Chung, et al.
Published: (2014-01-01)

Response to the gonadotropin releasing hormone agonist leuprolide in immature female sheep androgenized in utero
by: SERGIO E RECABARREN, et al.
Published: (2005-01-01)

Recurrent Endometrial Stromal Sarcoma: Treatment with a Progestin and Gonadotropin Releasing Hormone Agonist
by: Nefertiti Chianti duPont, et al.
Published: (2010-01-01)

The influence of gonadotropin-releasing hormone agonists on anthropometric change in girls with central precocious puberty
by: Jong Wan Yoon, et al.
Published: (2017-12-01)

Effects of Gonadotropin Releasing Hormone Agonist (Buserelin) on Development of Ovarian Follicles of Adult Rats
by: Tahmineh Peirouvi, et al.
Published: (2016-08-01)

Treatment outcomes of gonadotropin-releasing hormone agonist in obese girls with central precocious puberty
by: Hye Ryun Kim, et al.
Published: (2017-12-01)

The Role of Nitric Oxide in Controlled Ovarian Stimulation with Gonadotropin-Releasing Hormone Agonist and Antagonist
by: Lee Tsung-Hsien, et al.
Published: (2003)

Vaginal Expulsion of a Submucosal Myoma During Treatment with Long-Acting Gonadotropin-Releasing Hormone Agonist
by: Lily Wen, et al.
Published: (2006-06-01)

Triggering ovulation with gonadotropin-releasing hormone agonist versus human chorionic gonadotropin in polycystic ovarian syndrome. A randomized trial
by: Amr Hassaan Farag, et al.
Published: (2015-12-01)

Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone
by: Mo Kyung Jung, et al.
Published: (2014-12-01)

Evaluation of the impact of gonadotropin-releasing hormone agonist as an adjuvant in luteal-phase support on IVF outcome
by: Dattaprasad B Inamdar, et al.
Published: (2012-01-01)

Transient Arterial Hypertension Induced by Gonadotropin-Releasing Hormone Agonist Treatment for Central Precocious Puberty
by: Loukia Sifaki, et al.
Published: (2019-03-01)

Use of a Gonadotropin-Releasing Hormone Agonist to Manage Perimenopausal Women With Symptomatic Uterine Myomas
by: Peng-Hui Wang, et al.
Published: (2009-06-01)

Effect of vaginal estriol use in total laparoscopic hysterectomy with gonadotropin-releasing hormone agonist therapy
by: Go Hirata, et al.
Published: (2018-01-01)

Hormonal induction of spawning in 4 species of frogs by coinjection with a gonadotropin-releasing hormone agonist and a dopamine antagonist
by: Wignall Jacqui, et al.
Published: (2010-04-01)

Comparative multiplex analysis of cytokines, chemokines and growth factors in follicular fluid of normoresponder women undergoing ovum donation with gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist protocols
by: Neena Malhotra, et al.
Published: (2013-01-01)

The genes associated with gonadotropin-releasing hormone-dependent precocious puberty
by: Jin Soon Hwang
Published: (2012-01-01)

Pelvic Ultrasound in Diagnosing and Evaluating the Efficacy of Gonadotropin-Releasing Hormone Agonist Therapy in Girls With Idiopathic Central Precocious Puberty
by: Hong-kui Yu, et al.
Published: (2019-02-01)